stockrow
Saturday 31 October 2026
Export CME’s income statement to Excel — free account
CME Group Inc.
CME Financial Financial Data & Stock Exchanges
CME Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.5 billion, up 6.37% from fiscal 2024.
- Revenue
- +0.84%
- EPS
- +2.85%
- Free cash flow
- −11.2%
- Total debt
- +0.11%
Quarter to June 2026, against a year earlier
303.14
6.72
+2.27%
Follow CME
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 5 | 4 | 3 |
+8 more TTM periods Free account |
| 15.76% | 15.82% | 14.56% | 13.18% | ||
| 2.28% | 2.36% | 2.39% | 2.29% | ||
ROIC |
9.96% | 10.06% | 9.57% | 8.95% | |
Return on Tangible Assets |
130.92% | 126.38% | 74.12% | 104.14% | |
Average Days of Receivables |
40.59 | 50.52 | 35.78 | 36.68 | |
Free Cash Flow per Share |
11.68 | 12.05 | 11.66 | 11.35 | |
Free Cash Flow |
4,212.70 | 4,329.30 | 4,193.60 | 4,083.90 | |
Capital Expenditures |
(96.30) | (91.10) | (83.50) | (77.20) | |
| Other line items | |||||
Cash ROIC |
13.07% | 13.30% | 11.43% | 11.95% | |
Accounts Receivable Turnover |
9.53 | 7.92 | 10.76 | 10.06 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.23) | (0.24) | (0.24) | (0.22) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
26.25% | 25.88% | 26.25% | 25.88% | |
Share Based Compensation of Revenue |
1.47% | 1.41% | 1.45% | 1.45% | |
Interest Coverage |
25.21 | 25.28 | 24.39 | 24.40 | |
Operating CF/Net income |
1.01 | 1.04 | 1.06 | 1.12 | |
Depreciation/Fixed assets |
0.95 | 0.93 | 0.91 | 0.93 | |
Capex/Depreciation |
(0.29) | (0.27) | (0.25) | (0.23) | |
Revenue per Share |
18.78 | 18.81 | 18.13 | 17.79 | |
Operating CF per Share |
11.95 | 12.30 | 11.89 | 11.57 | |
Capex per Share |
(0.27) | (0.25) | (0.23) | (0.21) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates